News
BDXB
48.16
0.00%
0.00
BUZZ-Medtech: Clear split between gainers and losers in 2025
Reuters · 12/31/2025 12:45
EVP, CRO & President Life Sciences Michael Feld Reports Sale of BD Common Shares
Reuters · 12/29/2025 12:01
BD Announces Date for Upcoming Annual Shareholders Meeting
Reuters · 12/18/2025 16:27
BD Partners with Penn Institute to Advance Immunotherapy Research
Reuters · 12/18/2025 11:50
EVP Michael David Garrison Sells BD - Becton, Dickinson and Company Common Shares
Reuters · 12/18/2025 01:13
BD <BDX.N>: RBC RAISES TARGET PRICE TO $210 FROM $202
Reuters · 12/17/2025 04:26
BD Wins IVDR Certification for New VIASURE Diagnostic Assays in Europe
Reuters · 12/15/2025 21:40
BD EXPANDS BD MAX™ SYSTEM MENU WITH NEW IVDR-CERTIFIED VIASURE ASSAYS IN PARTNERSHIP WITH CERTEST BIOTEC
Reuters · 12/15/2025 21:40
BD Files Initial Statement of Beneficial Ownership for Interim CFO Vitor Roque
Reuters · 12/11/2025 23:28
Adagio Medical Holdings Appoints Sean Salmon to Board of Directors
Reuters · 12/11/2025 13:01
BD <BDX.N>: JEFFERIES RAISES TARGET PRICE TO $220 FROM $215
Reuters · 12/10/2025 06:53
BD Unveils Connected Medication Management Innovations at ASHP Midyear Clinical Meeting
Reuters · 12/08/2025 18:09
BD Partners with ChemoGLO to Advance Hazardous Drug Contamination Testing
Reuters · 12/04/2025 11:50
BD AND CHEMOGLO™ COLLABORATE TO EXPAND HAZARDOUS DRUG CONTAMINATION TESTING FOR HEALTH CARE FACILITIES AND LABORATORIES
Reuters · 12/04/2025 11:50
BD Launches New FACSDiscover A8 Cell Analyzers Globally
Reuters · 12/03/2025 11:50
BD EVP Michael Feld Reports Sale of Common Shares
Reuters · 12/02/2025 23:25
BD Files Initial Beneficial Ownership Statement for Director Robert Luther Huffines
Reuters · 12/02/2025 19:39
BD Files Initial Statement of Beneficial Ownership; Jacqueline Wright Named as Director
Reuters · 12/02/2025 19:36
DBAG Highlights Innovation and Sustainability at UNITY INNOVATION CIRCLE 2025
Reuters · 12/02/2025 09:00
BD Amends 8-K to Disclose Compensation for New Board Members
Reuters · 12/01/2025 21:18
More
Webull provides a variety of real-time BDXB stock news. You can receive the latest news about Becton Dickinson And Co through multiple platforms. This information may help you make smarter investment decisions.
About BDXB
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.